Strategies for treating Richters transformation in CLL: checkpoint inhibitors and venetoclax

Richters transformation remains a challenge in chronic lymphocytic leukemia (CLL). In this interview, Matthew Davids, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses the key approaches... Author: VJHemOnc Added: 01/11/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts